MedPath

How to Test Success of a Renal Denervation

Terminated
Conditions
Hypertension, Resistant to Conventional Therapy
Registration Number
NCT02559882
Lead Sponsor
University of Zurich
Brief Summary

The study aimed to assess the success of a clinically indicated renal denervation by different tests and correlate the results of the tests with the clinical outcome.

Detailed Description

We aim to test the response to adenosine infusion, cold pressure test, flow mediated dilation of renal artery before and after a clinical indicated renal denervation. Renal Denervation is not a study intervention

Recruitment & Eligibility

Status
TERMINATED
Sex
All
Target Recruitment
11
Inclusion Criteria

Male and female patients 18 years to 85 years of age, with a diagnosis of re-sistant hypertension (office sitting blood pressure >140/90 mmHg and 24-hour blood pressure >130/80 mmHg in patients treated with at least three antihypertensive drugs including a diuretic) and a clinical indication for a renal denervation.

Read More
Exclusion Criteria
  • Secondary cause of hypertension
  • Anatomical contraindication to renal denervation (renal artery diameter less than 4 mm or more than 8 mm), multiple renal artery, length to bifurcation less than 2 cm
  • Heart failure (normal ejection fractions on echocardiography and no clinical signs and symptoms of heart failure).
  • Alcohol or drug abuse,
  • Malignancy (unless healed or remission > 5 years)
  • Pregnancy
  • Know allergy to contrast medium
  • Participation in another study within the last month
Read More

Study & Design

Study Type
OBSERVATIONAL
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Response to adenosine infusion, cold pressure test, flow mediated dilation of renal artery before and 1 year after renal denervation Bchronic

Changes in blood pressure and heart rate, in renal artery diameter and flow during adenosine infusion before and 1 year after renal denervation

lood pressure (office and 24-hour blood pressure), laboratory parameter before and 12 months after catheter-based renal denrevationchronic
Secondary Outcome Measures
NameTimeMethod
Blood pressure (office and 24-hour blood pressure), laboratory parameter before and 1, 3, 6 months after catheter-basedchronic

Blood pressure (office and 24-hour blood pressure), laboratory parameter before and 1, 3, 6 months after catheter-based

Trial Locations

Locations (1)

Department of Cardiology University Heart Center Zurich University Hospital

🇨🇭

Zurich, Switzerland

© Copyright 2025. All Rights Reserved by MedPath